Fishing Stage - Forum
Home Active Topics Newest Pictures Search Login Register
The Attic
Big Pharma
May 6, 2023 17:23:58   #
EasternOZ Loc: Kansas City Metro
 
Makes me wonder why



Reply
May 6, 2023 18:09:15   #
Jer Loc: N. Illinois 🇺🇸
 
EasternOZ wrote:
Makes me wonder why


Good point.
Makes you truly wonder.

Reply
May 6, 2023 18:59:13   #
E.pa.al Loc: Martin's Creek
 
I'd bet it has something to do w SS🤔

Reply
 
 
May 7, 2023 00:48:13   #
Blackdog Loc: Round Rock, TX
 
Pretty sure it has to do with profit.
All the Governments paid for C***D v*****es.

Here is the AI answer(s):

HIV V*****e:

The development of an effective v*****e for HIV has been a challenging and complex task due to the unique properties of the v***s and the way it interacts with the i****e s****m. HIV is a highly mutable v***s, which means it can mutate rapidly and evade the immune response. Additionally, HIV infects and destroys the very cells of the i****e s****m that are necessary for mounting an effective immune response against the v***s.

There have been numerous attempts to develop an HIV v*****e, but so far, none have been successful in providing complete protection against the v***s. One of the major obstacles in developing an HIV v*****e is that the v***s is highly diverse, with multiple subtypes and strains circulating in different parts of the world. This makes it challenging to develop a v*****e that can provide broad protection against all strains of the v***s.

Another challenge is that HIV has evolved numerous strategies to evade the i****e s****m, such as by hiding inside cells and mutating rapidly. The v***s also targets and destroys the very immune cells that would normally be responsible for producing an effective immune response. These factors make it difficult to develop a v*****e that can effectively target and eliminate the v***s.

However, despite these challenges, researchers continue to work on developing an HIV v*****e. There are several promising v*****e candidates currently in clinical trials, and it is hoped that one of these may eventually lead to the development of an effective v*****e that can protect against HIV infection.

Cancer V*****e:

The development of a v*****e for cancer has been challenging because cancer is not caused by a single v***s or bacteria, but rather by a group of diseases that result from a******l growth and division of cells in the body. Unlike v***ses or bacteria, cancer cells are the body's own cells that have undergone mutations that cause them to grow and divide uncontrollably, leading to the development of tumors.

While v*****es work by stimulating the i****e s****m to recognize and eliminate foreign pathogens such as v***ses or bacteria, cancer cells are derived from the body's own cells, making it difficult for the i****e s****m to distinguish cancer cells from healthy cells. Additionally, cancer cells can develop mechanisms to evade the i****e s****m, making it even more challenging to develop a v*****e that can effectively target and eliminate cancer cells.

However, researchers have made significant progress in developing other types of cancer treatments, such as chemotherapy, radiation therapy, and immunotherapy. Immunotherapy, in particular, has shown promising results in recent years, by using drugs or other substances to stimulate the i****e s****m to recognize and attack cancer cells. While there is no single cure for cancer, these treatments, when used in combination or in conjunction with surgery, can help to manage and even cure some types of cancer. Additionally, ongoing research into cancer genetics and the i****e s****m is leading to the development of new and innovative cancer treatments, with the hope of eventually finding a cure for this complex disease.


Common Cold:

No, there is currently no v*****e for the common cold. The common cold is caused by a variety of v***ses, including rhinov***ses, c****av***ses, and adenov***ses, among others. These v***ses are highly diverse and mutate rapidly, which makes it difficult to develop a v*****e that can provide broad protection against all strains of the v***ses that cause the common cold.

Additionally, the symptoms of the common cold are generally mild, and most people recover without needing any specific treatment. Because of this, there has been less of a focus on developing a v*****e for the common cold compared to more serious illnesses such as influenza or C****-**.

However, there have been some attempts to develop v*****es for specific strains of the common cold v***s. For example, researchers have been working on developing a v*****e for human rhinov***s, which is one of the most common v***ses that cause the common cold. While these efforts have shown some promise in preclinical studies, no v*****e for the common cold is currently available for use in humans.

JUST FYI....Go ask AI

Reply
May 7, 2023 11:13:42   #
nutz4fish Loc: Colchester, CT
 
Blackdog wrote:
Pretty sure it has to do with profit.
All the Governments paid for C***D v*****es.

Here is the AI answer(s):

HIV V*****e:

The development of an effective v*****e for HIV has been a challenging and complex task due to the unique properties of the v***s and the way it interacts with the i****e s****m. HIV is a highly mutable v***s, which means it can mutate rapidly and evade the immune response. Additionally, HIV infects and destroys the very cells of the i****e s****m that are necessary for mounting an effective immune response against the v***s.

There have been numerous attempts to develop an HIV v*****e, but so far, none have been successful in providing complete protection against the v***s. One of the major obstacles in developing an HIV v*****e is that the v***s is highly diverse, with multiple subtypes and strains circulating in different parts of the world. This makes it challenging to develop a v*****e that can provide broad protection against all strains of the v***s.

Another challenge is that HIV has evolved numerous strategies to evade the i****e s****m, such as by hiding inside cells and mutating rapidly. The v***s also targets and destroys the very immune cells that would normally be responsible for producing an effective immune response. These factors make it difficult to develop a v*****e that can effectively target and eliminate the v***s.

However, despite these challenges, researchers continue to work on developing an HIV v*****e. There are several promising v*****e candidates currently in clinical trials, and it is hoped that one of these may eventually lead to the development of an effective v*****e that can protect against HIV infection.

Cancer V*****e:

The development of a v*****e for cancer has been challenging because cancer is not caused by a single v***s or bacteria, but rather by a group of diseases that result from a******l growth and division of cells in the body. Unlike v***ses or bacteria, cancer cells are the body's own cells that have undergone mutations that cause them to grow and divide uncontrollably, leading to the development of tumors.

While v*****es work by stimulating the i****e s****m to recognize and eliminate foreign pathogens such as v***ses or bacteria, cancer cells are derived from the body's own cells, making it difficult for the i****e s****m to distinguish cancer cells from healthy cells. Additionally, cancer cells can develop mechanisms to evade the i****e s****m, making it even more challenging to develop a v*****e that can effectively target and eliminate cancer cells.

However, researchers have made significant progress in developing other types of cancer treatments, such as chemotherapy, radiation therapy, and immunotherapy. Immunotherapy, in particular, has shown promising results in recent years, by using drugs or other substances to stimulate the i****e s****m to recognize and attack cancer cells. While there is no single cure for cancer, these treatments, when used in combination or in conjunction with surgery, can help to manage and even cure some types of cancer. Additionally, ongoing research into cancer genetics and the i****e s****m is leading to the development of new and innovative cancer treatments, with the hope of eventually finding a cure for this complex disease.


Common Cold:

No, there is currently no v*****e for the common cold. The common cold is caused by a variety of v***ses, including rhinov***ses, c****av***ses, and adenov***ses, among others. These v***ses are highly diverse and mutate rapidly, which makes it difficult to develop a v*****e that can provide broad protection against all strains of the v***ses that cause the common cold.

Additionally, the symptoms of the common cold are generally mild, and most people recover without needing any specific treatment. Because of this, there has been less of a focus on developing a v*****e for the common cold compared to more serious illnesses such as influenza or C****-**.

However, there have been some attempts to develop v*****es for specific strains of the common cold v***s. For example, researchers have been working on developing a v*****e for human rhinov***s, which is one of the most common v***ses that cause the common cold. While these efforts have shown some promise in preclinical studies, no v*****e for the common cold is currently available for use in humans.

JUST FYI....Go ask AI
Pretty sure it has to do with profit. br All the G... (show quote)


Thanks for posting this info, Blackdog.

Reply
May 7, 2023 15:46:39   #
DC Loc: Washington state
 
Blackdog wrote:
Pretty sure it has to do with profit.
All the Governments paid for C***D v*****es.

Here is the AI answer(s):

HIV V*****e:

The development of an effective v*****e for HIV has been a challenging and complex task due to the unique properties of the v***s and the way it interacts with the i****e s****m. HIV is a highly mutable v***s, which means it can mutate rapidly and evade the immune response. Additionally, HIV infects and destroys the very cells of the i****e s****m that are necessary for mounting an effective immune response against the v***s.

There have been numerous attempts to develop an HIV v*****e, but so far, none have been successful in providing complete protection against the v***s. One of the major obstacles in developing an HIV v*****e is that the v***s is highly diverse, with multiple subtypes and strains circulating in different parts of the world. This makes it challenging to develop a v*****e that can provide broad protection against all strains of the v***s.

Another challenge is that HIV has evolved numerous strategies to evade the i****e s****m, such as by hiding inside cells and mutating rapidly. The v***s also targets and destroys the very immune cells that would normally be responsible for producing an effective immune response. These factors make it difficult to develop a v*****e that can effectively target and eliminate the v***s.

However, despite these challenges, researchers continue to work on developing an HIV v*****e. There are several promising v*****e candidates currently in clinical trials, and it is hoped that one of these may eventually lead to the development of an effective v*****e that can protect against HIV infection.

Cancer V*****e:

The development of a v*****e for cancer has been challenging because cancer is not caused by a single v***s or bacteria, but rather by a group of diseases that result from a******l growth and division of cells in the body. Unlike v***ses or bacteria, cancer cells are the body's own cells that have undergone mutations that cause them to grow and divide uncontrollably, leading to the development of tumors.

While v*****es work by stimulating the i****e s****m to recognize and eliminate foreign pathogens such as v***ses or bacteria, cancer cells are derived from the body's own cells, making it difficult for the i****e s****m to distinguish cancer cells from healthy cells. Additionally, cancer cells can develop mechanisms to evade the i****e s****m, making it even more challenging to develop a v*****e that can effectively target and eliminate cancer cells.

However, researchers have made significant progress in developing other types of cancer treatments, such as chemotherapy, radiation therapy, and immunotherapy. Immunotherapy, in particular, has shown promising results in recent years, by using drugs or other substances to stimulate the i****e s****m to recognize and attack cancer cells. While there is no single cure for cancer, these treatments, when used in combination or in conjunction with surgery, can help to manage and even cure some types of cancer. Additionally, ongoing research into cancer genetics and the i****e s****m is leading to the development of new and innovative cancer treatments, with the hope of eventually finding a cure for this complex disease.


Common Cold:

No, there is currently no v*****e for the common cold. The common cold is caused by a variety of v***ses, including rhinov***ses, c****av***ses, and adenov***ses, among others. These v***ses are highly diverse and mutate rapidly, which makes it difficult to develop a v*****e that can provide broad protection against all strains of the v***ses that cause the common cold.

Additionally, the symptoms of the common cold are generally mild, and most people recover without needing any specific treatment. Because of this, there has been less of a focus on developing a v*****e for the common cold compared to more serious illnesses such as influenza or C****-**.

However, there have been some attempts to develop v*****es for specific strains of the common cold v***s. For example, researchers have been working on developing a v*****e for human rhinov***s, which is one of the most common v***ses that cause the common cold. While these efforts have shown some promise in preclinical studies, no v*****e for the common cold is currently available for use in humans.

JUST FYI....Go ask AI
Pretty sure it has to do with profit. br All the G... (show quote)


good information. I suppose they could release a v*****e for all of the above but what would be the point if it didn't keep you from getting the sickness, or spreading the sickness, or being hospitalized or even dieing from the sickness? who would take it and how would they make a profit
...unless of course they mandated everyone take it but that is crazy talk they would never do that

Reply
May 7, 2023 15:57:16   #
Kerry Hansen Loc: Bremerton, WA
 
EasternOZ wrote:
Makes me wonder why



Reply
 
 
May 7, 2023 22:03:22   #
farmer tom Loc: stockton california
 
Always follow the money!!!!!!!!!!!!!!!!!!!

Reply
May 7, 2023 23:25:43   #
FixorFish Loc: SW Oregon
 
Good post, Blackdog, thanks.
Regardless of the source being AI (a source that I, personally, find to be somewhat suspect), the explanation for why no cancer "v*****e" or "cure" sounded very much like the answer given to me by my brother, the M.D/PhD in Biochemistry guy, after spending about 55 years+ of his 82yrs working on development of that very "holy grail".
While he stated that he "approved" of the C***d ** v*****e(s), and urged everyone to get one, as well as boosters...."it is NOT a cure, it is mitigation....we haven't really found "true cures" for hardly any disease...EVER. And doubtful if we ever will."
When I responded with "Isn't that awfully pessimistic, coming from a guy who has had pretty much every tool and lab opportunity for the past half century ?"
He replied "I didn't make the biological/chemical rules, I just try to figure out how our species can keep going on, despite our challenges".

Spoken like a realist......not gonna blow smoke, just to see if there's any breeze.

Reply
May 8, 2023 21:05:22   #
Mooseman65 Loc: Seattle
 
Glad fish swim in schools, thank you for sharing that information 👍

Reply
May 8, 2023 22:43:34   #
Rheatown Loc: Greeneville tn
 
E.pa.al wrote:
I'd bet it has something to do w SS🤔


I’d say you’re right the v***s they created with our money and their shot was all about population control in my opinion

Reply
 
 
May 9, 2023 12:17:14   #
smitty Loc: maine
 
EasternOZ wrote:
Makes me wonder why


hmmmmmmmmmm

Reply
May 9, 2023 12:18:24   #
smitty Loc: maine
 
Blackdog wrote:
Pretty sure it has to do with profit.
All the Governments paid for C***D v*****es.

Here is the AI answer(s):

HIV V*****e:

The development of an effective v*****e for HIV has been a challenging and complex task due to the unique properties of the v***s and the way it interacts with the i****e s****m. HIV is a highly mutable v***s, which means it can mutate rapidly and evade the immune response. Additionally, HIV infects and destroys the very cells of the i****e s****m that are necessary for mounting an effective immune response against the v***s.

There have been numerous attempts to develop an HIV v*****e, but so far, none have been successful in providing complete protection against the v***s. One of the major obstacles in developing an HIV v*****e is that the v***s is highly diverse, with multiple subtypes and strains circulating in different parts of the world. This makes it challenging to develop a v*****e that can provide broad protection against all strains of the v***s.

Another challenge is that HIV has evolved numerous strategies to evade the i****e s****m, such as by hiding inside cells and mutating rapidly. The v***s also targets and destroys the very immune cells that would normally be responsible for producing an effective immune response. These factors make it difficult to develop a v*****e that can effectively target and eliminate the v***s.

However, despite these challenges, researchers continue to work on developing an HIV v*****e. There are several promising v*****e candidates currently in clinical trials, and it is hoped that one of these may eventually lead to the development of an effective v*****e that can protect against HIV infection.

Cancer V*****e:

The development of a v*****e for cancer has been challenging because cancer is not caused by a single v***s or bacteria, but rather by a group of diseases that result from a******l growth and division of cells in the body. Unlike v***ses or bacteria, cancer cells are the body's own cells that have undergone mutations that cause them to grow and divide uncontrollably, leading to the development of tumors.

While v*****es work by stimulating the i****e s****m to recognize and eliminate foreign pathogens such as v***ses or bacteria, cancer cells are derived from the body's own cells, making it difficult for the i****e s****m to distinguish cancer cells from healthy cells. Additionally, cancer cells can develop mechanisms to evade the i****e s****m, making it even more challenging to develop a v*****e that can effectively target and eliminate cancer cells.

However, researchers have made significant progress in developing other types of cancer treatments, such as chemotherapy, radiation therapy, and immunotherapy. Immunotherapy, in particular, has shown promising results in recent years, by using drugs or other substances to stimulate the i****e s****m to recognize and attack cancer cells. While there is no single cure for cancer, these treatments, when used in combination or in conjunction with surgery, can help to manage and even cure some types of cancer. Additionally, ongoing research into cancer genetics and the i****e s****m is leading to the development of new and innovative cancer treatments, with the hope of eventually finding a cure for this complex disease.


Common Cold:

No, there is currently no v*****e for the common cold. The common cold is caused by a variety of v***ses, including rhinov***ses, c****av***ses, and adenov***ses, among others. These v***ses are highly diverse and mutate rapidly, which makes it difficult to develop a v*****e that can provide broad protection against all strains of the v***ses that cause the common cold.

Additionally, the symptoms of the common cold are generally mild, and most people recover without needing any specific treatment. Because of this, there has been less of a focus on developing a v*****e for the common cold compared to more serious illnesses such as influenza or C****-**.

However, there have been some attempts to develop v*****es for specific strains of the common cold v***s. For example, researchers have been working on developing a v*****e for human rhinov***s, which is one of the most common v***ses that cause the common cold. While these efforts have shown some promise in preclinical studies, no v*****e for the common cold is currently available for use in humans.

JUST FYI....Go ask AI
Pretty sure it has to do with profit. br All the G... (show quote)


good info
thx b*****e!

Reply
If you want to reply, then register here. Registration is free and your account is created instantly, so you can post right away.
The Attic
FishingStage.com - Forum
Copyright 2018-2024 IDF International Technologies, Inc.